HEXO Exec Resignation Leads to Analyst Downgrade

Bank of America Merrill Lynch issued a downgrade for the Canadian cannabis producer after the abrupt departure of its CFO.

Quebec-based cannabis firm HEXO (TSX:HEXO,NYSE:HEXO) announced that CFO Michael Monahan stepped down from his executive role on Friday (October 4) after taking the position in May.

In a statement released shortly after trading hours on Friday, the former HEXO executive said he decided to leave the firm for family reasons, but will stay on as a consultant during the transition period.

“It has become apparent that this job requires me to spend the majority of my time in Gatineau and in Ottawa,” said Monahan. “This isn’t possible for me at this time given my family’s needs, and so I have decided to resign.”

Company shares fell 5.7 percent after trading hours on Friday, opening at C$5.11 on Monday (October 7).

In late May, Monahan’s appointment as CFO also came along with the establishment of HEXO USA in Delaware to help formalize the company’s presence in the US.

Monahan has been succeeded by Stephen Burwash, former vice president of strategic finance at HEXO. Burwash previously held the role of interim CFO prior to Monahan’s appointment after HEXO’s then-CFO Ed Chaplin confirmed he would also be transitioning out of the company.

The abrupt departure of Monahan raised some questions in the market about what’s happening behind the scenes at the marijuana producer.

It has also resulted in Bank of America Merrill Lynch downgrading the stock to a price target of C$4, less than half of its previous price target of C$9.

According to Bloomberg, Merrill Lynch analyst Christopher Carey wrote in a note to investors that there is no real way to know the expectations Monahan faced when he came into the role; nevertheless, his hasty resignation is a “concerning” marker of the inner workings of the company.

“We think it’s reasonable to assume the corporate finance organization was less developed than what Monahan had realized, perhaps indicating there remains much work to professionalizing said organization than what he (or the Street) fully appreciated,” wrote Carey.

The company saw another drop after the June release of its third quarter results, which missed the mark for some analysts.

HEXO reported C$13 million in net revenue for the period, up significantly from C$1.2 million in the same quarter last year, but BNN Bloomberg said that analysts expected revenues of C$14 million.

In a note to clients, RBC Capital Markets analyst Douglas Miehm said HEXO’s results were “a little light” when compared to estimates. Miehm did go on to note that the variance between RBC’s estimate and HEXO’s quarterly report was driven by the company’s performance in the medical business; adult-use segment results were in line with the RBC’s expectations.

Analyst consensus on TipRanks has the stock listed as a “moderate sell” with a price target of C$6.42, representing about a 26 percent upside over the current share price.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

Featured
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cronos Group Inc. resulting from allegations that Cronos may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Cronos securities you may be entitled to compensation without payment of any out of pocket fees or costs ...

-

read more Show less
Cronos Group Inc. is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 Management Cease Trade Orders . On November 9, 2021, the Company announced that it applied for a management cease trade order with the applicable securities regulatory authorities in Canada on the basis that the Company would be unable to file its Quarterly Report on Form ...

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company") is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 Management Cease Trade Orders (" NP 12-203 ").

On November 9, 2021, the Company announced that it applied for a management cease trade order (" MCTO ") with the applicable securities regulatory authorities in Canada on the basis that the Company would be unable to file its Quarterly Report on Form 10-Q for the period ended September 30, 2021 (the " Form 10-Q ") with the U.S. Securities and Exchange Commission (the " SEC "), together with its corresponding quarterly filings in Canada (collectively, the " Required Filings "), by the applicable filing deadlines (the " Original Announcement "). The MCTO was issued on November 16, 2021 and restricts all trading in securities of the Company, whether direct or indirect, by the Chief Executive Officer and Chief Financial Officer of the Company until two full business days following the filing of the Required Filings and the MCTO has been revoked. The MCTO does not affect the ability of other shareholders of the Company to trade their securities.

read more Show less
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cronos Group Inc. for violations of the securities lawsThe investigation focuses on whether the Company issued false andor misleading statements andor failed to disclose information pertinent to investors. Cronos filed a Form 8-K with the SEC on November 9, 2021, disclosing that the ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cronos Group Inc. ("Cronos" or "the Company") (NASDAQ:CRON) for violations of the securities laws

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Cronos filed a Form 8-K with the SEC on November 9, 2021, disclosing that the Company would "be required to restate its previously issued unaudited interim financial statements for the three and six months ended June 30, 2021" and that "the Company's financial statements for this period should therefore no longer be relied upon." Based on this news, shares of Cronos fell by nearly 16%.

read more Show less

MARKETS

Markets
TSX20633.27-128.76
TSXV897.13-13.09
DOW34580.08-59.71
S&P 5004538.43-38.67
NASD15085.47-295.85
ASX7241.20+16.00

COMMODITIES

Commodities
Gold1783.44+1.06
Silver22.54+0.03
Copper4.27-0.03
Palladium1816.01+10.01
Platinum936.31+3.31
Oil66.22-0.28
Heating Oil2.10-0.01
Natural Gas4.09+0.04